[The treatment of acute mycotic colpitis with ciclopiroxolamine (Dafnegin-CSC) in pregnant patients in the 10th lunar month].
Thirty-four patients at the end of pregnancy were treated with ciclopiroxolamine (Dafnegin) vaginally for the period from January to October 1998. The effect of therapy was evaluated. One hundred women were examined and 34 (34%) of them had vaginal candidiasis. All patients were treated with ciclopiroxolamine (Dafnegin) vaginal creme once time daily for 14 days. Thirty-two patients (94.11%) were healthy, in two patients (5.88) candidiasis was reduced to minimal colonies.
Novachkov
V
V
Damianov
L
L
Tsankova
M
M
Ivanov
S
S
D000208:Acute Disease; D000935:Antifungal Agents / Q000627:therapeutic use*; D002181:Candidiasis, Vulvovaginal / Q000188:drug therapy*; D000077768:Ciclopirox; D005260:Female; D006801:Humans; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy*; D011263:Pregnancy Trimester, Third; D011728:Pyridones / Q000627:therapeutic use*; D012074:Remission Induction; D014622:Vaginal Creams, Foams, and Jellies
D000935:Antifungal Agents; D011728:Pyridones; D014622:Vaginal Creams, Foams, and Jellies; D000077768:Ciclopirox